DrugAbuse reports Phase II Naltrexone data

DrugAbuse Sciences (Los Altos, Calif.) said that its naltrexone depot gave a 44% decrease in patients' drinking in a Phase II study. The 16 alcohol-dependent patients received a 300 mg injection of th...